Search results
EU approves Sanofi's Dupixent injection to treat chronic lung disease
Business Standard India· 1 day agoSanofi and partner Regeneron on Wednesday won European Union approval for wider use of their...
EMA approves Sanofi’s Dupixent for COPD treatment in adults
Pharmaceutical Technology· 24 hours agoThe European Medicines Agency (EMA) has approved Sanofi's Dupixent (dupilumab) as the first targeted...
Sanofi reports findings from Phase II relapsing MS treatment trial
Clinical Trials Arena· 3 days agoSanofi has reported the latest data from a Phase II clinical trial of a cluster of differentiation...
Sanofi eyes investment of up to $1.6 bln in Germany, Handelsblatt says - ET HealthWorld | Pharma
The Economic Times· 3 days agoThe paper cited German government sources as saying Sanofi changed course after initial...
Europe holds breath for France polls; Macron's role in EU to get diluted
Business Standard India· 4 hours agoWhen President Emmanuel Macron shocked France last month by calling a snap election, he was gambling...
Sanofi India - Closure of Trading Window
CNBC Awaaz· 3 days agoSanofi India - Closure of Trading Window
Xi Jinping greets EU Council president ahead of EV tariffs taking effect
Business Standard India· 5 hours agoChina's President Xi Jinping made a congratulatory call on Thursday to incoming European Council...
Here's why Joe Biden almost 'fell asleep on stage' during debate with Trump
Business Standard India· 1 day agoUS President Joe Biden admitted on Tuesday that he ‘fell asleep on the stage’ during last week’s...
PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar
BioPharma Dive· 6 days agoEuropean drug regulators voted for a third time not to renew the approval of Translarna. Elsewhere, ...
European Stocks Rise, Tracking Record-High Wall Street Close
Livemint· 16 hours agoThe CAC 40 Index outperformed at open, rising 0.7% as of 9:20 a.m. in Paris, as more than 200 candidates withdrew from France’s second election round in an effort to unite against Marine Le ...